Development of age-dependent glomerular lesions in galectin-3/AGE-receptor-3 knockout mice

被引:49
作者
Iacobini, C
Oddi, G
Menini, S
Amadio, L
Ricci, C
Di Pippo, C
Sorcini, M
Pricci, F
Pugliese, F
Pugliese, G
机构
[1] Univ Roma La Sapienza, Dipartimento Sci Clin Endocrinol, I-00161 Rome, Italy
[2] Ist Super Sanita, Dept Cell Biol & Neurosci, I-00161 Rome, Italy
关键词
age-related glomerulopathy; advanced glycation end-products; advanced glycation end-product receptors; oxidative stress;
D O I
10.1152/ajprenal.00435.2004
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Aging is characterized by renal functional and structural abnormalities resembling those observed in diabetes. These changes have been related to the progressive accumulation of advanced glycation end-products (AGEs) and cumulative oxidative stress occurring in both conditions. We previously reported that galectin-3 ablation is associated with increased susceptibility to diabetes- and AGE-induced glomerulopathy, thus indicating a protective role of galectin-3 as an AGE receptor. To investigate the role of the AGE/AGE receptor pathway in the pathogenesis of age-related renal disease, we evaluated the development of glomerular lesions in aging galectin-3 knockout ( KO) vs. wild-type (WT) mice and their relation to the increased AGE levels and oxidative stress characterizing the aging process. KO mice showed significantly more pronounced age-dependent increases in proteinuria, albuminuria, glomerular sclerosis, and glomerular and mesangial areas, starting at 18 mo, as well as renal extracellular matrix mRNA and protein expression, starting at 12 mo vs. age-matched WT mice. Circulating and renal AGEs, plasma isoprostane 8-epi-PGF(2 alpha) levels, glomerular content of the glycoxidation and lipoxidation products N-is an element of-carboxymethyllysine and 4-hydroxy-2-non-enal, and renal nuclear factor-kappa B activity also increased more markedly with age in KO than WT mice. AGE levels correlated significantly with renal functional and structural parameters. These data indicate that aging galectin-3 KO mice develop more pronounced changes in renal function and structure than coeval WT mice, in parallel with a more marked degree of AGE accumulation, oxidative stress, and associated low-grade inflammation, thus supporting the concept that the AGE/AGE receptor pathway is implicated in age-related renal disease.
引用
收藏
页码:F611 / F621
页数:11
相关论文
共 60 条
[1]  
ABRASS CK, 1995, AM J PATHOL, V146, P742
[2]   An advanced glycation endproduct cross-link breaker can reverse age-related increases in myocardial stiffness [J].
Asif, M ;
Egan, J ;
Vasan, S ;
Jyothirmayi, GN ;
Masurekar, MR ;
Lopez, S ;
Williams, C ;
Torres, RL ;
Wagle, D ;
Ulrich, P ;
Cerami, A ;
Brines, M ;
Regan, TJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (06) :2809-2813
[3]   Free radicals and aging [J].
Barja, G .
TRENDS IN NEUROSCIENCES, 2004, 27 (10) :595-600
[4]  
Baylis C, 1998, J AM SOC NEPHROL, V9, P699
[5]   Role of oxidative stress in diabetic complications - A new perspective on an old paradigm [J].
Baynes, JW ;
Thorpe, SR .
DIABETES, 1999, 48 (01) :1-9
[6]   Advanced glycation end product-induced activation of NF-kappa B is suppressed by alpha-lipoic acid in cultured endothelial cells [J].
Bierhaus, A ;
Chevion, S ;
Chevion, M ;
Hofmann, M ;
Quehenberger, P ;
Illmer, T ;
Luther, T ;
Berentshtein, E ;
Tritschler, H ;
Muller, M ;
Wahl, P ;
Ziegler, R ;
Nawroth, PP .
DIABETES, 1997, 46 (09) :1481-1490
[7]   Biochemistry and molecular cell biology of diabetic complications [J].
Brownlee, M .
NATURE, 2001, 414 (6865) :813-820
[8]   Aging and proinflammatory cytokines [J].
Bruunsgaard, H ;
Pedersen, M ;
Pedersen, BK .
CURRENT OPINION IN HEMATOLOGY, 2001, 8 (03) :131-136
[9]   IDENTIFICATION OF GALECTIN-3 AS A FACTOR IN PRE-MESSENGER-RNA SPLICING [J].
DAGHER, SF ;
WANG, JL ;
PATTERSON, RJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (04) :1213-1217
[10]   15th Golgi lecture:: from hyperglycaemia to the dysregulation of vascular remodelling in diabetes [J].
Di Mario, U ;
Pugliese, G .
DIABETOLOGIA, 2001, 44 (06) :674-692